Lockheed Martin 10-Qquarter ended 2026-06-28

Executive Summary

Lockheed Martin delivered higher production-driven sales and a sharp earnings recovery in Q2 2026, but favorable contract-estimate adjustments and the comparison with prior-year losses explain much of the rebound. Missile-defense growth and a $230B backlog support expansion, while recurring program charges show that stronger demand does not eliminate execution risk. H1 cash generation improved, aided by customer-receipt timing and lower tax payments; capital allocation favored dividends and debt repayment rather than buybacks. For investors, the opportunity is converting defense demand into durable profits and cash, with fixed-price overruns and the planned $3.45B Ultra Maritime acquisition the principal tests.

Key Financial Highlights

• Contract-estimate effects: Q2 adjustments contributed $296M to net earnings vs an $826M reduction a year earlier; that swing explains 75% of the earnings increase. H1 contributions were $466M, or $2.02 per diluted share—not equivalent to recurring operating improvement.
• Cash conversion: customer-receipt timing and lower tax payments drove improvement; working-capital cash use declined to $1.26B from $2.45B. Contract assets nevertheless rose $3.04B to $16.0B, highlighting continuing collection exposure.
• Capital return: H1 dividends totaled $1.61B; repurchases were zero vs $1.25B last year. Rounded outstanding shares increased from ≈229M to ≈230M; lower Y/Y weighted-average shares reflected earlier repurchases, not current-period shrinkage.

Business Developments

• Missile-defense expansion: Missiles and Fire Control Q2 sales rose 19% to $4.10B, driven by PAC-3, THAAD and Precision Strike Missile production. Backlog increased $36.8B during H1, primarily from an undefinitized THAAD contractual action; management expects ≈30% conversion to revenue within 12 months.
• F-35 scale: the program generated ≈28% of sales; Q2 deliveries totaled 19 aircraft, with 317 aircraft in backlog. Production supported Aeronautics growth, while sustainment helped services revenue.
• Uneven segment recovery: Aeronautics and Rotary and Mission Systems returned to Q2 profitability, largely against prior-year loss charges. Space H1 profit fell 12% to $652M despite higher sales, reflecting favorable completion performance in the prior year.
• Undersea expansion: the 7/6/2026 Ultra Maritime agreement would broaden undersea and anti-submarine capabilities; management expects Q4 2026 closing, subject to approvals, funded with cash and additional financing.

Risk Assessment

• Fixed-price execution: fixed-price contracts generated $22.5B of H1 sales; classified Aeronautics and missile programs carry ≈$1.8B and $1.5B of cumulative losses, leaving earnings exposed to further technical, schedule and cost revisions.
• Government concentration: U.S. Government customers represented 70% of H1 sales, making appropriations, procurement priorities and award timing decisive for backlog conversion and cash receipts.
• Production constraints: supplier, workforce and rare-earth availability can impede missile and aircraft ramps, while inflation increases exposure on fixed-price work.
• Acquisition and financing: Ultra Maritime requires approvals and successful integration; additional financing could constrain capital returns despite existing principal reductions.
• United Launch Alliance support: Vulcan Centaur difficulties prompted guarantees with maximum potential payments of $500M; further support or investment losses could consume cash.
• Legal and regulatory exposure: program-related securities litigation, government audits and investigations can produce penalties, payment suspension or contract restrictions.

This 10-Q lists no risk factors of its own and refers to the annual report. The risks above come from the rest of this filing. Full list: the company's 10-Ks on SEC.

Strategic Outlook and Investor Actionables

Management is betting on higher missile-defense output, sustained F-35 demand and broader maritime capabilities. The thesis requires converting orders into profitable deliveries without renewed program losses; demand is supportive, but execution and acquisition financing determine shareholder value.

• Missile ramp: starting from $7.75B of H1 segment sales and $1.09B of profit, later filings should show both growing; sales growth without profit growth would signal ramp inefficiency.
• F-35 execution: with 19 Q2 deliveries and 317 aircraft in backlog, higher deliveries without additional losses would validate execution; delays or new charges would undermine it.
• Ultra Maritime: the $3.45B transaction works if it closes and the acquired business grows inside Lockheed; integration losses, retrenchment or impairment would challenge the diversification thesis.
• Cash and capital: H1 FCF of $2.63B supported dividends and repayments; sustained conversion with contained contract-asset growth would validate earnings quality, while rising unbilled balances and financing needs would weaken it.